SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-23-003347
Filing Date
2023-05-12
Accepted
2023-05-12 16:30:45
Documents
48
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q celz_10q.htm   iXBRL 10-Q 504033
2 CERTIFICATION celz_ex311.htm EX-31.1 10909
3 CERTIFICATION celz_ex312.htm EX-31.2 10846
4 CERTIFICATION celz_ex321.htm EX-32.1 4162
5 CERTIFICATION celz_ex322.htm EX-32.2 4161
11 celz_10qimg1.jpg GRAPHIC 32619
  Complete submission text file 0001477932-23-003347.txt   2738766

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA celz-20230331.xsd EX-101.SCH 35542
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE celz-20230331_lab.xml EX-101.LAB 192959
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celz-20230331_cal.xml EX-101.CAL 30274
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celz-20230331_pre.xml EX-101.PRE 157500
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celz-20230331_def.xml EX-101.DEF 83876
42 EXTRACTED XBRL INSTANCE DOCUMENT celz_10q_htm.xml XML 286850
Mailing Address 211 E. OSBORN RD. PHOENIX AZ 85012
Business Address 211 E. OSBORN RD. PHOENIX AZ 85012 480-399-2822
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001187953 (see all company filings)

IRS No.: 870622284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41120 | Film No.: 23916310
SIC: 2836 Biological Products, (No Diagnostic Substances)